Pharmaceutical kits comprising mesenchymal stem cells
US8178084B2 · kind B2 · utility
4Cited by
12References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2003 |
| Grant date | May 15, 2012 |
| Priority date | — |
| Expiry date | Oct 26, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a natural soft skeletal tissue injury in a patient the method comprising administering to the patient a composition of mesenchymal stem cells in liquid suspension enriched compared to the natural source of said cells, or tenocytes derived therefrom. The method is particularly suited to the regeneration of tendons in competitive mammals, such as the superficial digital flexor tendon of the horse.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.